{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:03:37Z","timestamp":1785434617071,"version":"3.56.0"},"reference-count":59,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res Clin Pract"],"DOI":"10.36416\/1806-3756\/e20250478","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:54:17Z","timestamp":1778766857000},"page":"e20250478","source":"Crossref","is-referenced-by-count":0,"title":["Adalimumab-induced hypersensitivity pneumonitis: a rare reaction to a common dermatologic drug"],"prefix":"10.36416","author":[{"given":"Miguel","family":"Ribeiro","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lopes","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Cerqueira","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Manuel Nogueira","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Reis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Brito","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio","family":"Rodrigues","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Rolo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Dias Padr\u00e3o","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jjy0g33","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Braga"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref0","unstructured":"1. Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley"},{"key":"ref1","unstructured":"RG, et al. Adalimumab therapy for moderate to severe psoriasis:"},{"key":"ref2","unstructured":"a randomized, controlled phase III trial. J Am Acad Dermatol."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"2008;58(1):106-15. https:\/\/doi.org\/10.1016\/j.jaad.2007.09.010","DOI":"10.1016\/j.jaad.2007.09.010"},{"key":"ref4","unstructured":"2. Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld"},{"key":"ref5","unstructured":"SD, Choy EH, et al. Adalimumab for the treatment of patients"},{"key":"ref6","unstructured":"with moderately to severely active psoriatic arthritis: results of a"},{"key":"ref7","unstructured":"double\u2010blind, randomized, placebo\u2010controlled trial. Arthritis Rheum."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"2005;52(10):3279-89. https:\/\/doi.org\/10.1002\/art.21306","DOI":"10.1002\/art.21306"},{"key":"ref9","unstructured":"3. Lee HS, Jo KW, Shim TS, Song JW, Lee HJ, Hwang SW, et al. Six"},{"key":"ref10","unstructured":"Cases of Lung Injury Following Anti-tumour Necrosis Factor Therapy"},{"key":"ref11","unstructured":"for Inflammatory Bowel Disease. J Crohns Colitis. 2015;9(11):1053-"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"7. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv135","DOI":"10.1093\/ecco-jcc\/jjv135"},{"key":"ref13","unstructured":"4. Atzeni F, Boiardi L, Sall\u00ec S, Benucci M, Sarzi-Puttini P. Lung"},{"key":"ref14","unstructured":"involvement and drug-induced lung disease in patients with"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"rheumatoid arthritis. Expert Rev Clin Immunol. 2013;9(7):649-57.","DOI":"10.1586\/1744666X.2013.811173"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1586\/1744666X.2013.811173","DOI":"10.1586\/1744666X.2013.811173"},{"key":"ref17","unstructured":"5. Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, Pego-Reigosa"},{"key":"ref18","unstructured":"JM, Retamozo S, Bove A, et al. Interstitial lung disease induced"},{"key":"ref19","unstructured":"or exacerbated by TNF-targeted therapies: analysis of 122 cases."},{"key":"ref20","unstructured":"Semin Arthritis Rheum. 2011;41(2):256-64. https:\/\/doi.org\/10.1016\/j."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"semarthrit.2010.11.002","DOI":"10.1088\/1475-7516\/2010\/11\/002"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"6. Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V. Druginduced interstitial lung disease. Eur Respir J. 2022;60(4):2102776.","DOI":"10.1183\/13993003.02776-2021"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1183\/13993003.02776-2021","DOI":"10.1183\/13993003.02776-2021"},{"key":"ref24","unstructured":"7. Menter A, Gordon KB, Leonardi CL, Gu Y, Goldblum OM. Efficacy and"},{"key":"ref25","unstructured":"safety of adalimumab across subgroups of patients with moderate to"},{"key":"ref26","unstructured":"severe psoriasis. J Am Acad Dermatol. 2010;63(3):448-56. https:\/\/"},{"key":"ref27","unstructured":"doi.org\/10.1016\/j.jaad.2009.09.040"},{"key":"ref28","unstructured":"8. Huang Y, Weiji L, Zhe C, Yu W, Yao H, and Tu S. Effect of tumor"},{"key":"ref29","unstructured":"necrosis factor inhibitors on interstitial lung disease in rheumatoid"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"arthritis: angel or demon? Drug Des Devel Ther. 2019;13:2111-25.","DOI":"10.2147\/DDDT.S204730"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2147\/DDDT.S204730","DOI":"10.2147\/DDDT.S204730"},{"key":"ref32","unstructured":"9. Herrinton LJ, Harrold LR, Liu L, Raebel MA, Taharka A, Winthrop KL,"},{"key":"ref33","unstructured":"et al. Association between anti-TNF-\u03b1 therapy and interstitial lung"},{"key":"ref34","unstructured":"disease. Pharmacoepidemiol Drug Saf. 2013;22(4):394-402. https:\/\/"},{"key":"ref35","unstructured":"doi.org\/10.1002\/pds.3409"},{"key":"ref36","unstructured":"10. Dias OM, Pereira DA, Baldi BG, Costa AN, Athanazio RA, Kairalla RA,"},{"key":"ref37","unstructured":"et al. Adalimumab-induced acute interstitial lung disease in a patient"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"with rheumatoid arthritis. J Bras Pneumol. 2014;40(1):77-81. https:\/\/","DOI":"10.1590\/S1806-37132014000100012"},{"key":"ref39","unstructured":"doi.org\/10.1590\/S1806-37132014000100012"},{"key":"ref40","unstructured":"11. Tur\u00edbio DDCQ, Oliveira FCS, Barreto SMF, Jabour TBF. Interstitial"},{"key":"ref41","unstructured":"lung disease due to anti-TNF use in the treatment of psoriasis."},{"key":"ref42","unstructured":"An Bras Dermatol. 2021;96(4):447-50. https:\/\/doi.org\/10.1016\/j."},{"key":"ref43","unstructured":"abd.2020.08.016"},{"key":"ref44","unstructured":"12. Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I."},{"key":"ref45","unstructured":"Hypersensitivity pneumonitis: Current concepts in pathogenesis,"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"diagnosis, and treatment. Allergy. 2022;77(2):442-53. https:\/\/doi.","DOI":"10.1111\/all.15017"},{"key":"ref47","unstructured":"org\/10.1111\/all.15017"},{"key":"ref48","unstructured":"13. Guillon J, Joly P, Autran B, Denis M, Akoun G, Debre\u0301 P, et al."},{"key":"ref49","unstructured":"Minocycline-induced Cell-mediated Hypersensitivity Pneumonitis."},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Ann Inter Med. 1992;117(6):476-81. https:\/\/doi.org\/10.7326\/0003-","DOI":"10.7326\/0003-4819-117-6-476"},{"key":"ref51","unstructured":"4819-117-6-476"},{"key":"ref52","unstructured":"14. Salehi M, Miller R, Khaing M. Methotrexate-induced Hypersensitivity"},{"key":"ref53","unstructured":"Pneumonitis appearing after 30 years of use: a case report. J Med"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Case Rep. 2017;11(1):174. https:\/\/doi.org\/10.1186\/s13256-017-1333-0","DOI":"10.1186\/s13256-017-1333-0"},{"key":"ref55","unstructured":"15. Silva N, Ribeiro C, Almeida M, Malheiro J, Pedroso S, Martins M,"},{"key":"ref56","unstructured":"et al. Rituximab-induced hypersensitivity pneumonitis in a kidney"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"transplant patient. Port J Nephrol Hypert. 2020; 35(3):177-179.","DOI":"10.1007\/s00467-019-04380-x"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.32932\/pjnh.2020.10.091","DOI":"10.32932\/pjnh.2020.10.091"}],"container-title":["Respiratory Research &amp; Clinical Practice"],"original-title":[],"link":[{"URL":"https:\/\/www.ithenticate.com\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:54:59Z","timestamp":1778766899000},"score":1,"resource":{"primary":{"URL":"https:\/\/rrcpjournal.org\/article\/adalimumab-induced-hypersensitivity-pneumonitis-a-rare-reaction-to-a-common-dermatologic-drug\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":59,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250478","relation":{},"ISSN":["3086-3910"],"issn-type":[{"value":"3086-3910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"2025-0478"}}